Table 1 Patient characteristics

From: Patients with precursor disease exhibit similar psychological distress and mental HRQOL as patients with active myeloma

Variables

M (SD)

n

%

Age in years

62.1(10.5)

552

100

Sex

Female

 

228

41.3

Male

 

324

58.7

Stage of myeloma

Precusor disease (MGUS. SMM) (Group 1)

 

148

27.9

New diagnosis of MM (Group 2)

 

190

35.8

Treated MM (Group 3)

 

193

36.4

Comorbidity

Charlson comorbidity index ≤2

 

404

74.1

Charlson comorbidity index >2

 

141

25.9

Distress thermometer

5.4 (2.8)

529

 

Low (<5)

 

191

36.1

High (≥5)

 

338

63.9

Health-related quality of life

Physical component score (PCS 12)

39.1 (11.0)

541

 

Mental component score (MCS 12)

42.4 (11.6)

541

 

Anxiety (GAD-7) score

4.5 (4.4)

532

 

Anxiety level

None (0–4)

 

323

60.8

Mild (4–9)

 

142

26.7

Medium (10–14)

 

40

7.5

Severe (15–21)

 

26

4.9

Depression (PHQ-9) score

5.9 (4.6)

542

 

Depression level

None (0–4)

 

247

45.6

Mild (4–9)

 

181

33.4

Medium (10–14)

 

84

15.5

Severe (15–27)

 

30

5.5

  1. MM multiple myeloma, MGUS monoclonal gammopathy of undetermined significance, SMM smoldering myeloma, PCS physical component score, MCS mental component score, GAD-7 generalized anxiety disorder scale-7, PHQ-9 patient health questionnaire-9
Back to article page